Annual Report

Rapport Therapeutics, Inc. Filed 2025-03-11 Acc 0000950170-25-036828

Documents 1

2026-03-10 10-K Annual Report
2025-03-14 144 Sale of Securities
2025-03-13 4 Chief Financial Officer bought 10,000 shares at an average $10.10 ($100,988)
2025-03-13 4 Director bought 6,000 shares at $10.21 ($61,250)
2025-03-11 S-8 Securities Offered to Employees in Benefit Plans
2025-03-11 10-K Annual Report
2025-03-11 8-K Results of operations

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading rapp-20241231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…